Evidence map›Paper›PMID 27045293›Full record

ArticlePLoS neglected tropical diseases2016

The "Buruli Score": Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon.

Yolanda K Mueller, Mathieu Bastard, Patrick Nkemenang, Eric Comte, Geneviève Ehounou, Sara Eyangoh, Barbara Rusch, Earnest Njih Tabah, Laurence Toutous Trellu, Jean-Francois Etard

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Buruli ulcer in Africa: between innovation and pragmatism.Nature reviews. Disease primers · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Diagnostic Accuracy of Clinical and Microbiological Signs in Patients With Skin Lesions Resembling Buruli Ulcer in an Endemic Region.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Yolanda K MuellerEpicentre, Paris, France.
Mathieu BastardEpicentre, Paris, France.
Patrick NkemenangMédecins Sans Frontières, Geneva, Switzerland.
Eric ComteMédecins Sans Frontières, Geneva, Switzerland.
Geneviève EhounouMédecins Sans Frontières, Geneva, Switzerland.
Sara EyangohCentre Pasteur Cameroon, Yaounde, Cameroon.
Barbara RuschMédecins Sans Frontières, Geneva, Switzerland.
Earnest Njih TabahNational Yaws, Leishmaniasis, Leprosy and Buruli Ulcer Control Programme, Ministry of Public Health, Yaounde, Cameroon.
Laurence Toutous TrelluGeneva University Hospitals, Geneva, Switzerland.
Jean-Francois EtardEpicentre, Paris, France.
Médecins Sans Frontières · CHCentre Pasteur du Cameroun · CMInstitut de Recherche pour le Développement · FRMinistry of Public Health · CMUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccess to laboratory diagnosis can be a challenge for individuals suspected of Buruli Ulcer (BU). Our objective was to develop a clinical score to assist clinicians working in resource-limited settings for BU diagnosis. METHODODOLOGY/PRINCIPAL

findingsBetween 2011 and 2013, individuals presenting at Akonolinga District Hospital, Cameroon, were enrolled consecutively. Clinical data were collected prospectively. Based on a latent class model using laboratory test results (ZN, PCR, culture), patients were categorized into high, or low BU likelihood. Variables associated with a high BU likelihood in a multivariate logistic model were included in the Buruli score. Score cut-offs were chosen based on calculated predictive values. Of 325 patients with an ulcerative lesion, 51 (15.7%) had a high BU likelihood. The variables identified for the Buruli score were: characteristic smell (+3 points), yellow color (+2), female gender (+2), undermining (+1), green color (+1), lesion hyposensitivity (+1), pain at rest (-1), size >5cm (-1), locoregional adenopathy (-2), age above 20 up to 40 years (-3), or above 40 (-5). This score had AUC of 0.86 (95%CI 0.82-0.89), indicating good discrimination between infected and non-infected individuals. The cut-off to reasonably exclude BU was set at scores <0 (NPV 96.5%; 95%CI 93.0-98.6). The treatment threshold was set at a cut-off ≥4 (PPV 69.0%; 95%CI 49.2-84.7). Patients with intermediate BU probability needed to be tested by PCR. CONCLUSIONS/SIGNIFICANCE: We developed a decisional algorithm based on a clinical score assessing BU probability. The Buruli score still requires further validation before it can be recommended for wide use.

Indexed as

Decision Support TechniquesAdolescentAdultAgedAged, 80 and overBuruli UlcerCameroonChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedProspective Studies

Identifiers

PMID27045293
PMCPMC4821558
OpenAlexW2322641514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.